-
1
-
-
0003456441
-
-
3rd Ed., Marcel Dekker Inc. New York
-
Notari, R., Biopharmaceutics and Clinical Pharmacokinetics, An Introduction, 3rd Ed., Marcel Dekker Inc. New York, 1980, p152-54.
-
(1980)
Biopharmaceutics and Clinical Pharmacokinetics, An Introduction
, pp. 152-154
-
-
Notari, R.1
-
2
-
-
79960567388
-
-
3rd Ed., Varghese Publishing House, Bombay
-
Lechman, L., Liberman, H.A., Kanig, J.L., In., The Theory and Practice of Pharmacy, 3rd Ed., Varghese Publishing House, Bombay, 1987, p 430-453.
-
(1987)
The Theory and Practice of Pharmacy
, pp. 430-453
-
-
Lechman, L.1
Liberman, H.A.2
Kanig, J.L.3
-
3
-
-
0002504636
-
-
(Robinson, J. R., Lee, V.H. L., eds.) 2nd Ed. Marcel Dekker, New York
-
Li, V.H.K., Lee, V. H. L., In., Controlled Drug Delivery: Fundamentals and Applications (Robinson, J. R., Lee, V.H. L., eds.), 2nd Ed., Marcel Dekker, New York, 1987, p 4-36.
-
(1987)
Controlled Drug Delivery: Fundamentals and Applications
, pp. 4-36
-
-
Li, V.H.K.1
Lee, V.H.L.2
-
4
-
-
0024397878
-
Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate
-
W. Schaumann, Pharmacokinetics of isosorbide dinitrate and isosorbide-5-mononitrate, Int. J. Clin. Pharmacol. Ther. Toxicol. 27 (1989) 445-453.
-
(1989)
Int. J. Clin. Pharmacol. Ther. Toxicol.
, vol.27
, pp. 445-453
-
-
Schaumann, W.1
-
5
-
-
0019402775
-
First data on the effects and pharmacokinetics of isosorbide-5-mononitrate in normal man
-
U. Abshagen, S. Spörl-Radun, First data on the effects and pharmacokinetics of isosorbide-5-mononitrate in normal man, Eur. J. Clin.Pharmacol. 19 (1981) 423-429.
-
(1981)
Eur. J. Clin. Pharmacol.
, vol.19
, pp. 423-429
-
-
Abshagen, U.1
Spörl-Radun, S.2
-
6
-
-
0029090960
-
Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparation in healthy volunteers
-
V. Hutt, R. Bonn, E. Fritschi, H. Jaeger, Evaluation of the pharmacokinetics and absolute bioavailability of three isosorbide-5-mononitrate preparation in healthy volunteers, Arzneim.-Forsch./Drug Res.45 (1995) 142-145.
-
(1995)
Arzneim. -Forsch. /Drug Res.
, vol.45
, pp. 142-145
-
-
Hutt, V.1
Bonn, R.2
Fritschi, E.3
Jaeger, H.4
-
7
-
-
0021440892
-
Toleranzentwicklung hinsichtlich der antiischamischen Wirkung von Isosorbiddinitratbei regelmassiger, mehrfach taglicher Verabreichung
-
G. Reiniger, R. Blasini, U. Brügmann, W. Rudolph, Toleranzentwicklung hinsichtlich der antiischamischen Wirkung von Isosorbiddinitratbei regelmassiger, mehrfach taglicher Verabreichung, Herz 9 (1984)146-152.
-
(1984)
Herz
, vol.9
, pp. 146-152
-
-
Reiniger, G.1
Blasini, R.2
Brügmann, U.3
Rudolph, W.4
-
8
-
-
0023926191
-
Influence of the time of dosage of isosorbide mononitrate on objective and subjective anginapectoris parameters
-
H. Herrmann, A. Kuhl, H. Maier-Lenz, Influence of the time of dosage of isosorbide mononitrate on objective and subjective anginapectoris parameters, Arzeim.-Forsch./Drug Res. 38 (1988) 694-698.
-
(1988)
Arzeim. -Forsch. /Drug Res.
, vol.38
, pp. 694-698
-
-
Herrmann, H.1
Kuhl, A.2
Maier-Lenz, H.3
-
9
-
-
0030769480
-
Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris:effects on quality of life indices
-
M.G. Niemeyer, H.A. Kleinjans, R. de Ree, A.H. Zwinderman, T.J.Cleophas, E.E. vander Wall, Comparison of multiple-dose and once-daily nitrate therapy in 1212 patients with stable angina pectoris:effects on quality of life indices. Dutch mononitrate quality of life (DUMQOL) study group, Angiology 48 (1997) 855-862.
-
(1997)
Dutch mononitrate quality of life (DUMQOL) study group, Angiology
, vol.48
, pp. 855-862
-
-
Niemeyer, M.G.1
Kleinjans, H.A.2
de Ree, R.3
Zwinderman, A.H.4
Cleophas, T.J.5
vander Wall, E.E.6
-
11
-
-
79952011869
-
Formulation and evaluation of oral controlled release Glimepiride matrix tablets
-
Raparla DV and Murthy TE. Formulation and evaluation of oral controlled release Glimepiride matrix tablets. Adv. Phamacol. Toxical. 2007; 8(2): 59-62.
-
(2007)
Adv. Phamacol. Toxical.
, vol.8
, Issue.2
, pp. 59-62
-
-
Raparla, D.V.1
Murthy, T.E.2
-
12
-
-
79952034259
-
-
2nd Ed., Marcel Dekker Inc., New York
-
Liberman, H.A., Leon Lachman, Schwartz J.B., Pharmaceutical Dosage forms, 2nd Ed., Vol III, Marcel Dekker Inc., New York, 1992, p 256.
-
(1992)
Pharmaceutical Dosage forms
, vol.3
, pp. 256
-
-
Liberman, H.A.1
Lachman, L.2
Schwartz, J.B.3
-
13
-
-
0004170639
-
-
th Ed. The Controller of Publication, Govt. of India, Delhi
-
th Ed. The Controller of Publication, Govt. of India, Delhi, 1996, A82-A85.
-
(1996)
The Indian Pharmacopoeia
, vol.2
-
-
-
14
-
-
84455192610
-
-
Inc., Rockville, MD
-
The United States Pharmacopoeia, United states Pharmacopoeial convention, Inc., Rockville, MD, 2000, 1944.
-
(1944)
The United States Pharmacopoeia, United states Pharmacopoeial convention
, vol.2000
-
-
-
16
-
-
79952033830
-
Design and evaluation of chitason matrix of metoprolol tartrate for sustained release
-
Shabaraya AR and Narayanacharyulu R. Design and evaluation of chitason matrix of metoprolol tartrate for sustained release. J. Pharm. Pharmaceutical Sci. 2000; 8(1): 231-236.
-
(2000)
J. Pharm. Pharmaceutical Sci.
, vol.8
, Issue.1
, pp. 231-236
-
-
Shabaraya, A.R.1
Narayanacharyulu, R.2
-
17
-
-
35748941143
-
Formulation and evaluation of sustained release tablets using an insoluble rosin matrix system
-
Shirwaikar AA, Jacob S and Grover V. Formulation and evaluation of sustained release tablets using an insoluble rosin matrix system. Indian J. Pharm. Sci. 2005; 67 (1): 80-83
-
(2005)
Indian J. Pharm. Sci.
, vol.67
, Issue.1
, pp. 80-83
-
-
Shirwaikar, A.A.1
Jacob, S.2
Grover, V.3
-
18
-
-
77957598474
-
Once dailymatrix tablet of azithromicine in-vitro and in-vivo evaluation
-
Roldy RK, Midovert S and Redlen S. Once dailymatrix tablet of azithromicine in-vitro and in-vivo evaluation. Pharm. Sci. Tech. 2003; 4(4):55-59
-
(2003)
Pharm. Sci. Tech.
, vol.4
, Issue.4
, pp. 55-59
-
-
Roldy, R.K.1
Midovert, S.2
Redlen, S.3
|